• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IPA
Click for more information
0.00% 4.5¢

INDIGO PROPERTIES AUSTRALIA LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
IPANotice of Annual General Meeting/Proxy Form02/11/09
IPAAppendix 4E 30 June 200931/08/09
IPAShareholder update21/08/09
IPAChange of Share Registry address18/08/09
IPAIndigo Pacific Capital update to shareholders07/08/09
IPACorrection of error in Australian Financial Review05/08/09
IPAResponse to ASX Query re LR3.19A22/07/09
IPAFinal Director's Interest Notice21/07/09
IPAFinal Director's Interest Notice21/07/09
IPAUpdate to market07/07/09
IPAUpdate on Indigo loan30/06/09
IPAIndigo Pacific Capital Borrower in Voluntary Administration23/06/09
IPAUpdate on Indigo Private Group17/06/09
IPAUpdate on loan recoverability05/06/09
IPASuspension from Official QuotationPRICE SENSITIVE01/06/09
IPAHalf Year Accounts27/02/09
IPAHalf-year results 31 December 200827/02/09
IPAAppendix 4D December 2008PRICE SENSITIVE27/02/09
IPAImpairment ProvisionPRICE SENSITIVE19/02/09
IPACeasing to be a substantial holder10/02/09
IPABecoming a substantial holder13/01/09
IPACeasing to be a substantial holder16/12/08
IPAResults of Meeting27/11/08
IPAAGM Presentation26/11/08
IPAMD's Address to ShareholdersPRICE SENSITIVE26/11/08
IPAChairman's Address to Shareholders26/11/08
IPANotice of Annual General Meeting/Proxy Form
02/11/09
IPAAppendix 4E 30 June 2009
31/08/09
IPAShareholder update
21/08/09
IPAChange of Share Registry address
18/08/09
IPAIndigo Pacific Capital update to shareholders
07/08/09
IPACorrection of error in Australian Financial Review
05/08/09
IPAResponse to ASX Query re LR3.19A
22/07/09
IPAFinal Director's Interest Notice
21/07/09
IPAFinal Director's Interest Notice
21/07/09
IPAUpdate to market
07/07/09
IPAUpdate on Indigo loan
30/06/09
IPAIndigo Pacific Capital Borrower in Voluntary Administration
23/06/09
IPAUpdate on Indigo Private Group
17/06/09
IPAUpdate on loan recoverability
05/06/09
IPASuspension from Official Quotation
01/06/09PRICE SENSITIVE
IPAHalf Year Accounts
27/02/09
IPAHalf-year results 31 December 2008
27/02/09
IPAAppendix 4D December 2008
27/02/09PRICE SENSITIVE
IPAImpairment Provision
19/02/09PRICE SENSITIVE
IPACeasing to be a substantial holder
10/02/09
IPABecoming a substantial holder
13/01/09
IPACeasing to be a substantial holder
16/12/08
IPAResults of Meeting
27/11/08
IPAAGM Presentation
26/11/08
IPAMD's Address to Shareholders
26/11/08PRICE SENSITIVE
IPAChairman's Address to Shareholders
26/11/08
refresh Created with Sketch. REFRESH
 

Top Stories

Cyclone signs MOU with Vale for development of Iron Bear play

Cyclone Metals Lt has signed a Memorandum of Understanding with Vale S.A to support development of the former's iron ore project in Canada
Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado Blue Star Helium (ASX:BNL) has won approval from Colorado regulators to drill five fresh helium wells at its flagship.
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch CuFe Ltd (ASX:CUF) has decided not to wait around for Northern Star's Crossroads mine to get up and running, selling its $4M royalty right.
InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.